Claims for Patent: 5,876,710

Summary for Patent: 5,876,710

Title:	Compounds and compositions for delivering active agents
Abstract:	Carrier compounds, compositions, and dosage unit forms therefor which are useful in the delivery of active agents are provided. The present invention provides a compound having the formula: ##STR1## or a salt thereof, wherein the compound may be used in a composition or dosage unit form for delivery of at least one active agent, including a peptide, mucopolysaccharide, carbohydrate, or a lipid. Methods of administration and preparation of the compounds and compositions of the invention are provided as well, including oral administration. Further, the compositions of the invention may be prepared by mixing at least one active agent, at least one carrier compound, and, optionally, a dosing vehicle.
Inventor(s):	Leone-Bay; Andrea (Ridgefield, CT), Wang; Eric (Yonkers, NY), Sarubbi; Donald J. (Bronxville, NY), Leipold; Harry (Elmsford, NY)
Assignee:	Emisphere Technologies Inc. (Tarrytown, NY)
Application Number:	08/796,335
Patent Claims:	1. A composition comprising: (A) at least one active agent; and (B) a compound having the following formula ##STR10## or a salt thereof. 2. A composition as defined in claim 1, wherein said active agent is selected from the group consisting of a biologically active agent, a chemically active agent, and a combination thereof. 3. A composition as defined in claim 2, wherein said biologically active agent comprises at least one peptide, mucopolysaccharide, carbohydrate, and lipid. 4. The composition as defined in claim 2, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, parathyroid hormone, desferrioxamine (DFO), and any combination thereof. 5. A composition as defined in claim 4, wherein said biologically active agent comprises an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, oxytocin, vasopressin, vancomycin, DFO, parathyroid hormone, or combinations thereof. 6. A composition as defined in claim 2, wherein said biologically active agent comprises heparin. 7. A composition as defined in claim 2, wherein said biologically active agent comprises low molecular weight heparin. 8. A composition as defined in claim 1, further comprising a carrier selected from the group consisting of a poly(amino acid) and a polypeptide. 9. A dosage unit form comprising: (A) a composition as defined in claim 1; and (B) (a) an excipient (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof. 10. A dosage unit form as defined in claim 9, wherein said active agent is selected from the group consisting of a biologically active agent, a chemically active agent, and a combination thereof. 11. A dosage unit form as defined in claim 10, wherein said biologically active agent comprises at least one peptide, mucopolysaccharide, carbohydrate, and lipid. 12. The dosage unit form as defined in claim 10, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, parathyroid hormone, desferrioxamine (DFO), and any combination thereof. 13. A dosage unit form as defined in claim 12, wherein said biologically active agent comprises an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, oxytocin, vasopressin, vancomycin, DFO, parathyroid hormone, or combinations thereof. 14. A dosage unit form as defined in claim 10, wherein said biologically active agent comprises heparin. 15. A dosage unit form as defined in claim 10, wherein said biologically active agent comprises low molecular weight heparin. 16. A dosage unit form as defined in claim 9, comprising a tablet, a capsule, or a liquid. 17. A dosage unit form as defined in claim 16, wherein said dosing vehicle is selected from the group consisting of water, 1,2-propane diol, ethanol, and any combination thereof. 18. A method for administering a biologically-active agent to an animal in need of said agent, said method comprising administering orally to said animal a composition as defined in claim 2. 19. A compound having the formula ##STR11## or a salt thereof. 20. A method for preparing a composition, said method comprising mixing: (A) at least one active agent; (B) at least one compound as defined in claim 1; and (C) optionally, a dosing vehicle.

Details for Patent 5,876,710

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2039-02-26